K. Michael Conaway sold Sanofi ADR (NASDAQ: SNY)
K. Michael Conaway (R-TX), a U.S. Representative, has disclosed 1 trade in Sanofi ADR (SNY) since 2016, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: K. Michael Conaway sold $1,001 - $15,000 of Sanofi ADR (NASDAQ: SNY) on September 12, 2016. Since that trade, SNY is up +70.04% against the S&P 500 up +294.83%, an outperformance of -224.80%.
Data updated
K. Michael Conaway's SNY trades vs the price
SNY is up +70.04% since K. Michael Conaway sold on September 12, 2016, versus +294.83% for the S&P 500.
Performance since this trade
All K. Michael Conaway SNY trades
K. Michael Conaway & SNY trading FAQ
Is it legal for K. Michael Conaway to trade Sanofi ADR (SNY) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Sanofi ADR (SNY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did K. Michael Conaway sell SNY?
K. Michael Conaway disclosed a sale of $1,001 - $15,000 of Sanofi ADR (SNY) on September 12, 2016, according to public STOCK Act filings.
How has SNY performed since K. Michael Conaway's trade?
Since K. Michael Conaway sold SNY on September 12, 2016, the stock is up +70.04%, versus +294.83% for the S&P 500 over the same period, an outperformance of -224.80%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional SNY trades?
Quantellect tracks every disclosed congressional trade in Sanofi ADR (SNY) on the Sanofi ADR congressional trading page, which aggregates filings across all members of Congress.
K. Michael Conaway's SNY tradesAll congressional filings for Sanofi ADRK. Michael Conaway's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.